...MYCN amplification. The in vivo efficacy of glycolyic inhibition was tested using NAMPT inhibitors in MYCN-amplified pat...
...MYCN amplification. Timely identification of a germline RB1 mutation in blood samples or either somatic RB1 mutation or ...
...Mycn, and Pim1 genes. In addition, it is of note that viral integration and overexpression of the Zfp521 gene was detect...
...MYCN in normal basal prostate cells drives formation of metastatic NEPC.
...MYCN, CCND1, CCND2, EGFR and FNDC3A was successful in detecting neoplasia with an overall accuracy of 54% in S-CRN compa...
...MYCN 15%. Residents in provinces with a higher EHDI had a better 5-year survival (57% vs. 41% for lower EHDI) and higher...
...MYCN amplification, while additional alterations may be required for tumor development. However, the view on single nucl...
...MYCN. However, MYCN is a transcription factors that was considered a poor drug target, until recent approaches suggested...
...MYCN-induced neuroblastomas that arise in these precursors, and that the GTPase-activating protein (GAP)-related domain ...
...MYCN. In vivo, xenografts showed significant inhibition of growth during the period of treatment, and rapid regrowth aft...
联系地址
山东省济南市章丘区文博路2号
齐鲁师范学院 genelibs生信实验室
山东省济南市高新区舜华路750号
大学科技园北区F座4单元2楼
电话： 0531-88819269
版权所有 © 2025.Genelibs 济南弘晖生物技术有限公司 鲁ICP备20007159号-2
